Stocksigma LogoStocksigma Logo

Solara Active Pharma Reports Strong Q2 FY27 Turnaround with Net Profit at ₹28.46 Crore

Solara Active Pharma Sciences reported consolidated revenue from operations of ₹417.34 crore for Q2 ended 30th Sep'26, up 33.1% YoY from ₹313.54 crore and

Solara Active Pharma Reports Strong Q2 FY27 Turnaround with Net Profit at ₹28.46 Crore

Solara Active Pharma Sciences Ltd · Outcome · 16 Oct 2026, 7:06 pm

Solara Active Pharma Reports Strong Q2 FY27 Turnaround with Net Profit at ₹28.46 Crore Solara Active Pharma Sciences reported consolidated revenue from operations of ₹417.34 crore for Q2 ended 30th Sep'26, up 33.1% YoY from ₹313.54 crore and 9.4% QoQ from ₹381.60 crore. Net profit stood at ₹28.46 crore, rebounding sharply from a net loss of ₹10.10 crore in Q2 ended 30th Sep'25 and up 74.5% QoQ from ₹16.31 crore, despite an exceptional loss of ₹4.50 crore on Vizag plant CWIP sale. Diluted EPS reached ₹5.92. Standalone Q2 revenue was ₹417.34 crore with net profit of ₹29.61 crore.

Original exchange filing (PDF)

More announcements from Solara Active Pharma Sciences Ltd

All Solara Active Pharma Sciences Ltd announcements